Deferoxamine is poorly absorbed orally, so it is not likely to reach the bloodstream of the infant or cause any adverse effects in breastfed infants.[1] Limited information indicates that maternal doses of deferoxamine up to 2 grams daily do not affect iron levels in breastmilk and did not cause any adverse effects in two breastfed infants.[2] Some experts advocate breastfeeding in women receiving deferoxamine for iron overload caused by beta-thalassemia.[3] However, since little published information is available on the use of deferoxamine during breastfeeding, monitoring of the infant's serum iron is recommended.